XML 56 R41.htm IDEA: XBRL DOCUMENT v3.19.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Schedule of Share Option Activity
   
2018
   
2017
   
2016
 
   
Number
of share options
   
Weighted average exercise price
   
Number
of share options
   
Weighted average exercise price
   
Number
of share options
   
Weighted average exercise price
 
Outstanding as of beginning of year
   
580,185
   
$
9.64
     
2,278,089
   
$
9.92
     
5,878,270
   
$
6.84
 
Granted
   
--
     
--
     
--
     
--
     
207,890
     
12.19
 
Exercised
   
(70,271
)
   
10.19
     
(1,611,489
)
   
9.27
     
(3,649,754
)
   
4.82
 
Terminated
   
(921
)
   
9.82
     
(77,292
)
   
25.89
     
(97,063
)
   
21.34
 
Forfeited
   
(500
)
   
4.42
     
(9,123
)
   
8.06
     
(61,254
)
   
7.25
 
Outstanding as of end of year
   
508,493
     
9.58
     
580,185
     
9.64
     
2,278,089
     
9.92
 
Options exercisable as of end of year
   
485,579
   
$
9.46
     
459,662
   
$
8.51
     
1,606,983
   
$
10.19
 
 
Schedule of Restricted Shares Units Activity
 
2018
   
2017
   
2016
 
   
Number
of RSU
   
Weighted Average
Fair Value
   
Number
of RSU
   
Weighted Average
Fair Value
   
Number
of RSU
   
Weighted Average
Fair Value
 
Outstanding as of beginning of year
   
1,245,889
   
$
21.29
     
1,009,184
   
$
14.62
     
773,200
   
$
15.11
 
Granted
   
977,667
     
20.80
     
818,856
     
24.88
     
359,643
     
12.83
 
Converted
   
(602,423
)
   
17.86
     
(553,241
)
   
14.71
     
(86,847
)
   
11.45
 
Forfeited
   
(21,837
)
   
22.11
     
(28,910
)
   
16.42
     
(36,812
)
   
14.73
 
Outstanding as of end of year
   
1,599,296
   
$
22.27
     
1,245,889
   
$
21.29
     
1,009,184
   
$
14.62
 
Schedule of Information about Share Options Outstanding
The following table summarizes information about employees’ share options outstanding as of December 31, 2018:

Outstanding
   
Exercisable
 
Range of exercise prices
   
Number outstanding
   
Weighted average remaining contractual life (in years)
   
Weighted average exercise price
   
Number exercisable
   
Weighted average exercise price
 
$
4.42 - 17.25
     
508,493
     
3.08
   
$
9.58
     
485,579
   
$
9.46
 
 
Schedule of Intrinsic and Fair Values for Options Exercised
 
Year ended December 31,
 
   
2018
   
2017
   
2016
 
The intrinsic value of options exercised
 
$
1,416
   
$
26,031
   
$
40,314
 
The original fair value of options exercised
 
$
302
   
$
7,202
   
$
16,711
 
Schedule of Intrinsic and Fair Values for RSU's Exercised
 
Year ended December 31,
 
   
2018
   
2017
   
2016
 
The intrinsic value of converted RSU's
 
$
15,840
   
$
12,996
   
$
1,177
 
The original fair value of converted RSU's
 
$
10,761
   
$
8,138
   
$
994
 
Schedule of Stock-Based Compensation Expense in Statement of Operations
Stock-based compensation expenses were recognized in the Statement of Operations as follows:

   
Year ended December 31,
 
   
2018
   
2017
   
2016
 
Cost of goods
 
$
3,141
   
$
3,084
   
$
3,920
 
Research and development, net
   
2,533
     
2,555
     
2,119
 
Marketing, general and administrative
   
6,987
     
6,010
     
3,367
 
Total stock-based compensation expense
 
$
12,661
   
$
11,649
   
$
9,406
 
Schedule of Fair Value of Options Granted
The Company estimated the fair value, utilizing the following assumptions for the year 2016 (all in weighted averages):
 
   
2016
 
Risk-free interest rate
   
0.9%-1.3%  
 
Expected life of options
 
4.60 years
 
Expected annual volatility
   
47%-48%  
Expected dividend yield
 
None